How does semaglutide ordering work on RxFul?

RxFul's Rx-GLP tier ($0/mo) includes GLP product access with a standard white-label patient portal template and 3PL fulfillment, which makes semaglutide reachable without a monthly platform fee. That tier excludes peptides and limits catalog scope to GLP lines. Compounded semaglutide is typically dispensed in multi-dose vials, and a titration program draws escalating doses from those vials as the patient steps up. Concentrations and vial sizes depend on the specific 503A partner pharmacy, so confirm the formulary in a demo rather than assuming a fixed catalog.

This page is about ordering workflow, not clinical dosing. The platform's job is to make the right vial reach the patient with a correct SIG and licensure handled. RxFul optimizes the patient-facing branded checkout path; Fizy Health optimizes prescriber-side batch checkout when clinic staff place orders for many patients in one session.

Two failure points dominate semaglutide ordering on RxFul. The first is pricing visibility: RxFul publishes SaaS tiers ($0 through $1,997/mo) but does not list pass-through per-vial semaglutide cost on rxful.com, so a program owner cannot see landed cost before tier selection and onboarding. For a business whose margin is the spread on one molecule, that is the single most important number to confirm. The second is workflow fit: RxFul routes orders through a clinic-branded patient portal, not a prescriber batch cart, so a refill day with dozens of titration lines may not match how your ops team actually works.

Fizy Health is the same multi-pharmacy 503A category but builds around prescriber ops. Per-vial 503A cost shows on each catalog and cart line before checkout, the whole refill day goes into one validated clinic cart, and steady patients can move to auto-ship so a titration program keeps shipping on schedule. Compare your top five semaglutide SKUs on landed cost before checkout rather than assuming either platform wins GLP-1 on marketing alone.